Quaggin Susan's most recent trade in Abbvie Inc was a trade of 81 Stock Equivalent Units done . Disclosure was reported to the exchange on June 30, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
AbbVie | Susan E. Quaggin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2025 | 81 | 562 | - | - | Stock Equivalent Units | |
AbbVie | Susan E. Quaggin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2025 | 1,203 | 2,525 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
AbbVie | Susan E. Quaggin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2025 | 71 | 476 | - | - | Stock Equivalent Units | |
AbbVie | Susan E. Quaggin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2024 | 84 | 401 | - | - | Stock Equivalent Units | |
AbbVie | Susan E. Quaggin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2024 | 75 | 314 | - | - | Stock Equivalent Units | |
AbbVie | Susan E. Quaggin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2024 | 87 | 236 | - | - | Stock Equivalent Units | |
AbbVie | Susan E. Quaggin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2024 | 1,322 | 1,322 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
AbbVie | Susan E. Quaggin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2024 | 82 | 147 | - | - | Stock Equivalent Units | |
AbbVie | Quaggin Susan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2023 | 64 | 64 | - | - | Stock Equivalent Units |